- Fever and leukocytosis related to terconazole vaginal suppository.
Fever and leukocytosis related to terconazole vaginal suppository.
Southern medical journal (1994-07-01)
S S Hyder, J E Manjon, N M Gantz
PMID8023214
ZUSAMMENFASSUNG
We describe a 22-year-old woman who developed fever, shaking chills, and leukocytosis after insertion of a terconazole (80 mg) vaginal suppository for mild vaginal candidiasis. The patient became afebrile and asymptomatic 24 hours after hospital admission without antibiotic therapy. More experience with terconazole is needed before it can be considered as safe as other imidazole derivatives that have been available for more than 15 years.
MATERIALIEN
Produktnummer
Marke
Produktbeschreibung
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Terconazol, European Pharmacopoeia (EP) Reference Standard
Preise und Verfügbarkeit sind derzeit nicht verfügbar.